Breathe BioMedical
PrivateLast Round
IPO
Oct 28, 2024
Total Funding Raised
$1.02M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Breathe BioMedical operates in Healthcare & Life Sciences and is based in Moncton, New Brunswick. Its latest recorded funding round was a VC Round in June 2022.
Breathe BioMedical is a medical technology company that is developing a breath analytics platform for the early detection of diseases, with an initial focus on breast cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Breathe BioMedical Comparables
Compare Breathe BioMedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Menssana Research Inc. | 78% | |
| Owlstone Medical | 77% | |
| Breath Diagnostics | 76% |
For institutional investors. Book with your work email.
Breathe BioMedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Oct 28, 2024 | ||||
| VC Round | Jun 9, 2022 | ||||
| VC Round | Jun 9, 2022 | ||||
| Grant | Feb 4, 2022 | ||||
| Grant | May 29, 2019 | ||||
Grant | Feb 12, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Breathe BioMedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Brunswick Innovation Foundation | VC Round, Grant |
| Atlantic Canada Opportunities Agency | VC Round, Grant |
| Maxim Group | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 8, 2026
Open roles increased to 39, 139% of headcount.
- Jul 20, 2026
Open roles increased to 39, 139% of current headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 13, 2026
Breathe BioMedical Inc. works with The George Washington University as part of a multi-centre observational study that collects breath profiles to support early breast cancer detection, particularly for women with dense breasts.
- is_developingOct 13, 2026
As of Oct 13th '26, Breathe BioMedical Inc. is developing a breath analytics platform for early disease detection while expanding its multi-centre study to IWK Health’s Breast Health Research Unit in Halifax, Nova Scotia, to support breast cancer detection for women with dense breasts.
For institutional investors. Book with your work email.
Breathe BioMedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Breathe BioMedical's valuation, stock price, and market status.
Is Breathe BioMedical a public or private company?
Breathe BioMedical is a private company.
What is the current stock price of Breathe BioMedical?
Breathe BioMedical is a private company, so its shares have no public market price. Caplight tracks Breathe BioMedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Breathe BioMedical worth (valuation)?
Valuation information for Breathe BioMedical is not publicly available.
Can I buy Breathe BioMedical stock?
Breathe BioMedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Breathe BioMedical's last funding round?
Breathe BioMedical's most recent funding round was IPO on October 28, 2024.
Who are the main investors in Breathe BioMedical?
Key investors in Breathe BioMedical include Maxim Group.
Will Breathe BioMedical IPO soon?
No public IPO plans have been announced for Breathe BioMedical.
How can I track Breathe BioMedical secondary market activity?
Caplight tracks bids, offers, and trades in Breathe BioMedical's shares on secondary markets.